Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Tania Garron"'
Autor:
Dylan M. Johnson, Terry Juelich, Lihong Zhang, Jennifer K. Smith, Birte K. Kalveram, David Perez, Jeanon Smith, Michael R. Grimes, Tania Garron, Maricela Torres, Shane Massey, Trevor Brasel, David W. C. Beasley, Alex N. Freiberg, Jason E. Comer
Publikováno v:
Viruses, Vol 16, Iss 7, p 1101 (2024)
Favipiravir is a ribonucleoside analogue that has been explored as a therapeutic for the treatment of Ebola Virus Disease (EVD). Promising data from rodent models has informed nonhuman primate trials, as well as evaluation in patients during the 2013
Externí odkaz:
https://doaj.org/article/930a651013754a5698d362b0dbc18049
Autor:
Chien-Te Tseng, Elena Sbrana, Naoko Iwata-Yoshikawa, Patrick C. Newman, Tania Garron, Robert L. Atmar, Clarence J. Peters, Robert B. Couch
Publikováno v:
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://doaj.org/article/49a910483cbc413f97e96d12d00aa2f2
Autor:
Chien-Te Tseng, Elena Sbrana, Naoko Iwata-Yoshikawa, Patrick C Newman, Tania Garron, Robert L Atmar, Clarence J Peters, Robert B Couch
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35421 (2012)
BACKGROUND:Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was ini
Externí odkaz:
https://doaj.org/article/66f6819a9ae64dd6a9554ef487f9924c
Autor:
Dylan M. Johnson, Trevor Brasel, Shane Massey, Jeanon Smith, Tania Garron, Shannon Wallace, Xiaoying Yu, David W. Beasley, Jason E. Comer
Publikováno v:
Journal of Virology. 97
This study is the first to examine the Kikwit strain of EBOV, the most commonly used strain, in the gold-standard macaque model of infection. Additionally, this is the first description of the detection of virus in the vitreous fluid, an immune privi
Autor:
Dylan M. Johnson, Trevor Brasel, Shane Massey, Tania Garron, Michael Grimes, Jeanon Smith, Maricela Torres, Shannon Wallace, Alejandro Villasante-Tezanos, David W. Beasley, Jason E. Comer
Publikováno v:
Antiviral Research. 209:105492
Molnupiravir (EIDD-2801) is a prodrug of a ribonucleoside analogue that is currently being used under a US FDA emergency use authorization for the treatment of mild to moderate COVID-19. We evaluated molnupiravir for efficacy as an oral treatment in
Autor:
Tania Garron, Bin Gong, Yuan Qiu, Eric C Gong, Thomas G. Ksiazek, Yakun Liu, Jason E. Comer, Changcheng Zhou, Junying Zheng, Zhengchen Su, Paul J. Boor, Trevor Brasel, Yang Jin, Y Whitney Yin, Qing Chang
Publikováno v:
Pathogens, Vol 10, Iss 509, p 509 (2021)
Pathogens
bioRxiv
Volume 10
Issue 5
Pathogens
bioRxiv
Volume 10
Issue 5
The SARS-CoV-2 pandemic has inspired renewed interest in understanding the fundamental pathology of acute respiratory distress syndrome (ARDS) following infection because fatal COVID-19 cases are commonly linked to respiratory failure due to ARDS. Th
Autor:
Robert B. Couch, Krishna Narayanan, Xinrong Tao, Chien Te K. Tseng, Bi Hung Peng, Abdullah Algaissi, Anurodh S. Agrawal, Tania Garron
Publikováno v:
Human Vaccines & Immunotherapeutics
To determine if a hypersensitive-type lung pathology might occur when mice were given an inactivated MERS-CoV vaccine and challenged with infectious virus as was seen with SARS-CoV vaccines, we prepared and vaccinated mice with an inactivated MERS-Co
Autor:
Lu Lu, Shibo Jiang, Tania Garron, Chien Te K. Tseng, Maki Wakamiya, Robert B. Couch, Lanying Du, Teh Sheng Chan, Anurodh S. Agrawal, Xinrong Tao, Bi Hung Peng, Abdullah Algaissi
Publikováno v:
Journal of Virology
Characterized animal models are needed for studying the pathogenesis of and evaluating medical countermeasures for persisting Middle East respiratory syndrome-coronavirus (MERS-CoV) infections. Here, we further characterized a lethal transgenic mouse
Autor:
Bi Hung Peng, Xinrong Tao, Chien Te K. Tseng, Maki Wakamiya, Teh Sheng Chan, Robert B. Couch, Tania Garron, Anurodh S. Agrawal
Publikováno v:
Journal of Virology
The emergence of Middle East respiratory syndrome-coronavirus (MERS-CoV) in the Middle East since 2012 has caused more than 900 human infections with ∼40% mortality to date. Animal models are needed for studying pathogenesis and for development of
Autor:
Rudragouda Channappanavar, Chien Te K. Tseng, Naru Zhang, Lu Lu, Xinrong Tao, Tania Garron, Jian Tang, Shibo Jiang, Stanley Perlman, Yusen Zhou, Cuiqing Ma, Sumaiya Tasneem, Lanying Du, Lili Wang
Publikováno v:
Cellular & Molecular Immunology
Cellular and Molecular Immunology
Cellular and Molecular Immunology
Middle East respiratory syndrome (MERS), an emerging infectious disease caused by MERS coronavirus (MERS-CoV), has garnered worldwide attention as a consequence of its continuous spread and pandemic potential, making the development of effective vacc